Justin Bowers
Stock Analyst at Deutsche Bank
(1.73)
# 3,210
Out of 4,906 analysts
49
Total ratings
35.48%
Success rate
1.22%
Average return
Main Sectors:
Stocks Rated by Justin Bowers
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WAT Waters | Maintains: Hold | $310 → $325 | $281.66 | +15.39% | 3 | Nov 4, 2024 | |
| IQV IQVIA Holdings | Maintains: Buy | $270 → $265 | $158.96 | +66.71% | 2 | Nov 1, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $28 → $23 | $4.66 | +393.56% | 3 | Aug 20, 2024 | |
| CON Concentra Group Holdings Parent | Initiates: Buy | $29 | $19.95 | +45.36% | 1 | Aug 19, 2024 | |
| AMED Amedisys | Downgrades: Hold | $101 | $97.71 | +3.37% | 11 | Jul 31, 2024 | |
| MEDP Medpace Holdings | Maintains: Hold | $395 → $336 | $308.88 | +8.78% | 2 | Jul 24, 2024 | |
| TXG 10x Genomics | Downgrades: Hold | $55 → $25 | $11.54 | +116.64% | 3 | Jul 10, 2024 | |
| RGEN Repligen | Upgrades: Buy | $180 → $155 | $114.80 | +35.02% | 2 | Jun 26, 2024 | |
| TMO Thermo Fisher Scientific | Maintains: Buy | $600 → $610 | $404.94 | +50.64% | 3 | Apr 25, 2024 | |
| TECH Bio-Techne | Maintains: Buy | $85 → $82 | $50.27 | +63.12% | 2 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $23 → $25 | $12.34 | +102.59% | 3 | Apr 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $23 → $17 | $2.38 | +614.29% | 3 | Aug 8, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $280 → $300 | $139.63 | +114.85% | 2 | Jul 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $310 → $275 | $188.07 | +46.22% | 2 | Apr 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $250 | $210.08 | +19.00% | 1 | Dec 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $350 → $290 | $149.79 | +93.60% | 1 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $42 → $46 | $14.51 | +217.02% | 5 | May 10, 2021 |
Waters
Nov 4, 2024
Maintains: Hold
Price Target: $310 → $325
Current: $281.66
Upside: +15.39%
IQVIA Holdings
Nov 1, 2024
Maintains: Buy
Price Target: $270 → $265
Current: $158.96
Upside: +66.71%
Fortrea Holdings
Aug 20, 2024
Maintains: Hold
Price Target: $28 → $23
Current: $4.66
Upside: +393.56%
Concentra Group Holdings Parent
Aug 19, 2024
Initiates: Buy
Price Target: $29
Current: $19.95
Upside: +45.36%
Amedisys
Jul 31, 2024
Downgrades: Hold
Price Target: $101
Current: $97.71
Upside: +3.37%
Medpace Holdings
Jul 24, 2024
Maintains: Hold
Price Target: $395 → $336
Current: $308.88
Upside: +8.78%
10x Genomics
Jul 10, 2024
Downgrades: Hold
Price Target: $55 → $25
Current: $11.54
Upside: +116.64%
Repligen
Jun 26, 2024
Upgrades: Buy
Price Target: $180 → $155
Current: $114.80
Upside: +35.02%
Thermo Fisher Scientific
Apr 25, 2024
Maintains: Buy
Price Target: $600 → $610
Current: $404.94
Upside: +50.64%
Bio-Techne
Apr 18, 2024
Maintains: Buy
Price Target: $85 → $82
Current: $50.27
Upside: +63.12%
Apr 18, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $12.34
Upside: +102.59%
Aug 8, 2023
Maintains: Buy
Price Target: $23 → $17
Current: $2.38
Upside: +614.29%
Jul 14, 2023
Maintains: Buy
Price Target: $280 → $300
Current: $139.63
Upside: +114.85%
Apr 27, 2023
Maintains: Buy
Price Target: $310 → $275
Current: $188.07
Upside: +46.22%
Dec 14, 2022
Initiates: Hold
Price Target: $250
Current: $210.08
Upside: +19.00%
Jul 14, 2022
Maintains: Buy
Price Target: $350 → $290
Current: $149.79
Upside: +93.60%
May 10, 2021
Maintains: Buy
Price Target: $42 → $46
Current: $14.51
Upside: +217.02%